Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy
Recruiting now
Conditions studied: Acute Ischemic Stroke
In brief
Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy. This registry aims to establish quantified risk stratification and prognostic models, as well as suggest effective diagnostic and therapeutic strategies.
Key facts
- Study ID
- NCT06882577
- Run by
- Soochow University
- People needed
- 400
- Starts
- 2025-03-31
- Expected to finish
- 2029-03-31
- Last updated by the study team
- 2025-05-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Written informed consent by patient
- Age ≥ 18 years
- Acute ischemic stroke (with matching brain lesion on MR imaging)
- Enrolment within 24 h after onset of stroke-related symptoms.
You may not qualify if…
- Pregnancy and / or breast-feeding.
- Participation in an interventional study.
- Patients refuse to participate in the research.
Where it is running
- The first affiliated hospital of soochow university — Suzhou, Jiangsu, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.